作者: Susanne B. Haga , Huntington F. Willard
DOI: 10.1038/NRG2003
关键词:
摘要: Many achievements in the genome sciences have been facilitated by policies that prioritized research, secured funding and raised public health-professional awareness. Such should address ethical, legal social concerns, are as important to scientific commercial development of field science itself. On occasion, policy issues take precedence over science, particularly when impasses encountered or health money is at stake. Here we discuss spectrum current debates policy, how actively engage all affected stakeholders promote effective making.